Notice2021-14165
Spring Valley Family Pharmacy; Decision and Order
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
July 2, 2021
Issuing agencies
Justice DepartmentDrug Enforcement Administration
Full Text
<html>
<head>
<title>Federal Register, Volume 86 Issue 125 (Friday, July 2, 2021)</title>
</head>
<body><pre>
[Federal Register Volume 86, Number 125 (Friday, July 2, 2021)]
[Notices]
[Pages 35336-35338]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2021-14165]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Spring Valley Family Pharmacy; Decision and Order
On April 12, 2021, the Assistant Administrator, Diversion Control
Division, Drug Enforcement Administration (hereinafter, Government),
issued an Order to Show Cause (hereinafter, OSC) to Spring Valley
Family Pharmacy (hereinafter, Registrant) of Gallipolis, Ohio. OSC, at
1. The OSC proposed the revocation of Registrant's Certificate of
Registration (hereinafter, registration) No. FS7068249. Id. It alleged
that Registrant ``currently lacks state authority to handle controlled
substances.'' Id. (citing 21 U.S.C. 824(a)(3)).
Specifically, the OSC alleged that on or about October 2, 2020,
Registrant permanently and voluntarily surrendered its Ohio state
pharmacy license to the State of Ohio Board of Pharmacy with the
surrender effective on October 5, 2020. Id. at 2. According to the OSC,
Registrant permanently and voluntarily surrendered its Ohio state
pharmacy license ``after its owner and primary operator, Brandon
O'Callaghan, permanently and voluntarily surrendered his state
pharmacist license after testing positive for controlled substances in
violation of a Board Order.'' Id. The OSC concluded that because
Registrant is ``currently without authority to handle controlled
substances in Ohio, the state in which [Registrant] is registered with
DEA. . . . DEA must revoke [Registrant's] registration. . . .'' Id.
The OSC notified Registrant of the right to request a hearing on
the allegations or to submit a written statement, while waiving the
right to a hearing, the procedures for electing each option, and the
consequences for failing to elect either option. Id. at 2-3 (citing 21
CFR 1301.43). The OSC also notified Registrant of the opportunity to
submit a corrective action plan. Id. at 3 (citing 21 U.S.C.
824(c)(2)(C)).
Adequacy of Service
In a Declaration dated June 8, 2021, a Diversion Investigator
(hereinafter, the DI) assigned to the Charleston District Office,
Louisville Field Division, stated that she and a Tactical Diversion
Squad Group Supervisor traveled to the residence of Brandon
O'Callaghan, the former owner and pharmacist for Spring Valley Family
Pharmacy, in Winfield, West Virginia on April 26, 2021. Request for
Final Agency Action, dated June 9, 2021 (hereinafter, RFAA), Exhibit
(hereinafter, RFAAX) 3 at 1. The DI stated that on that date, she
``personally handed Mr. O'Callaghan a copy of the [OSC].'' Id. The DI
also stated that ``Mr. O'Callaghan signed Form DEA-12 Receipt for Cash
or Other Items, which indicated that he received a copy of the [OSC].''
Id. In her Declaration, the DI included a true and correct copy of the
DEA-12 that Mr. O'Callaghan signed. RFAAX 3, Appendix (hereinafter,
App.) A.
The Government forwarded its RFAA, along with the evidentiary
record, to this office on June 10, 2021. In its RFAA, the Government
represents that ``[Registrant] has not submitted a timely request for a
hearing in this matter.'' \1\ RFAA, at 1.
---------------------------------------------------------------------------
\1\ The Government included a second DI Declaration, dated June
9, 2021, in its RFAA, which stated that ``DEA has not received any
correspondence from Spring Valley Family Pharmacy concerning the
[OSC].'' RFAAX 4, at 2.
---------------------------------------------------------------------------
The Government seeks to ``revoke the [DEA COR] of [Registrant]
because [Registrant] lacks authority to handle controlled substances in
the State of Ohio, the state where [Registrant] is registered with
DEA.'' Id. The Government requests that the Administrator revoke
Registrant's DEA registration. Id. at 5.
Based on the DI's Declaration, the Government's written
representations, and my review of the record, I find that the
Government accomplished service of the OSC on Registrant on April 26,
2021. I also find that more than thirty days have now passed since the
Government accomplished service of the OSC. Further, based on the
Government's written representations, I find that neither Registrant,
nor anyone purporting to represent the Registrant, requested a hearing,
submitted a written statement while waiving Registrant's
[[Page 35337]]
right to a hearing, or submitted a corrective action plan. Accordingly,
I find that Registrant has waived the right to a hearing and the right
to submit a written statement and corrective action plan. 21 CFR
1301.43(d) and 21 U.S.C. 824(c)(2)(C). I, therefore, issue this
Decision and Order based on the record submitted by the Government,
which constitutes the entire record before me. 21 CFR 1301.43(e).
Findings of Fact
Registrant's DEA Registration
Registrant is the holder of DEA Certificate of Registration No.
FS7068249 at the registered address of 448 Jackson Pike, Gallipolis, OH
45631. RFAAX 1 (Certificate of Registration). Pursuant to this
registration, Registrant is authorized to dispense controlled
substances in schedules II through V as a retail pharmacy. Id.
The Status of Registrant's State License
On October 5, 2020, the State of Ohio Board of Pharmacy
(hereinafter, Board) issued a ``Settlement Agreement with the State of
Ohio Board of Pharmacy'' (hereinafter, Settlement Agreement). RFAAX 4,
App. A. According to the Settlement Agreement, the Board had initiated
an investigation of Registrant, a pharmacy licensed as a ``Terminal
Distributor of Dangerous Drugs,'' and Brandon O'Callaghan, owner and
operator of Registrant, related to Mr. O'Callaghan's ``illicit drug
usage and failure to ensure [Registrant] [met] minimum standards and
maintained sanitary compounding area conditions to ensure public
safety.'' Id. at 1. The Settlement Agreement states that on or about
June 19, 2019, the Board sent Registrant a Summary Suspension/Notice of
Opportunity for Hearing and that Registrant subsequently requested a
hearing by and through counsel on or about July 15, 2019. Id. The
hearing was held on or about November 5, 2019, and resulted in a Board
Order that placed both Registrant's license and Mr. O'Callaghan's
license on indefinite suspension subject to certain conditions. Id. at
2. According to the Settlement Agreement, on or about January 8, 2020,
Mr. O'Callaghan violated the terms of the Order by ``testing positive
for amphetamine (454 ng/ml) and methamphetamine (2368 ng/ml).'' Id.
According to the Settlement Agreement, Mr. O'Callaghan subsequently
surrendered his pharmacy license on May 5, 2020, and thus Registrant
``no longer [had] a Responsible Person or owner that [was] lawfully
allowed to possess'' its license. Id. Under the terms of the Settlement
Agreement, Registrant permanently and voluntarily surrendered to the
Board its license and registration. Id. at 2.
According to Ohio's online records, of which I take official
notice, Registrant's state pharmacy license remains inactive.\2\
<a href="https://elicense.ohio.gov/OH_HomePage">https://elicense.ohio.gov/OH_HomePage</a> (last visited date of signature
of this Order). Accordingly, I find that Registrant is not currently
licensed to dispense controlled substances in Ohio, the state in which
Registrant is registered with the DEA.
---------------------------------------------------------------------------
\2\ Under the Administrative Procedure Act, an agency ``may take
official notice of facts at any stage in a proceeding--even in the
final decision.'' United States Department of Justice, Attorney
General's Manual on the Administrative Procedure Act 80 (1947) (Wm.
W. Gaunt & Sons, Inc., Reprint 1979). Pursuant to 5 U.S.C. 556(e),
``[w]hen an agency decision rests on official notice of a material
fact not appearing in the evidence in the record, a party is
entitled, on timely request, to an opportunity to show the
contrary.'' Accordingly, Registrant may dispute my finding by filing
a properly supported motion for reconsideration of finding of fact
within fifteen calendar days of the date of this Order. Any such
motion and response shall be filed and served by email to the other
party and to Office of the Administrator, Drug Enforcement
Administration at <a href="/cdn-cgi/l/email-protection#8eeaebefa0efeaeae1a0effafae1fce0ebf7fdceeaebefa0fbfdeae1e4a0e9e1f8"><span class="__cf_email__" data-cfemail="482c2d2966292c2c2766293c3c273a262d313b082c2d29663d3b2c2722662f273e">[email protected]</span></a>.
---------------------------------------------------------------------------
Discussion
Pursuant to 21 U.S.C. 824(a)(3), the Attorney General is authorized
to suspend or revoke a registration issued under section 823 of the
Controlled Substances Act (hereinafter, CSA) ``upon a finding that the
registrant . . . has had his State license or registration suspended .
. . [or] revoked . . . by competent State authority and is no longer
authorized by State law to engage in the . . . dispensing of controlled
substances.'' With respect to a practitioner, the DEA has also long
held that the possession of authority to dispense controlled substances
under the laws of the state in which a practitioner engages in
professional practice is a fundamental condition for obtaining and
maintaining a practitioner's registration. See, e.g., James L. Hooper,
M.D., 76 FR 71,371 (2011), pet. for rev. denied, 481 F. App'x 826 (4th
Cir. 2012); Frederick Marsh Blanton, M.D., 43 FR 27,616, 27,617 (1978).
This rule derives from the text of two provisions of the CSA.
First, Congress defined the term ``practitioner'' to mean ``a pharmacy
. . . or other person licensed, registered, or otherwise permitted, by
. . . the jurisdiction in which [it] practices . . ., to distribute,
dispense, . . . [or] administer . . . a controlled substance in the
course of professional practice.'' 21 U.S.C. 802(21). Second, in
setting the requirements for obtaining a practitioner's registration,
Congress directed that ``[t]he Attorney General shall register
practitioners . . . if the applicant is authorized to dispense . . .
controlled substances under the laws of the State in which he
practices.'' 21 U.S.C. 823(f). Because Congress has clearly mandated
that a practitioner possess state authority in order to be deemed a
practitioner under the CSA, the DEA has held repeatedly that revocation
of a practitioner's registration is the appropriate sanction whenever
he is no longer authorized to dispense controlled substances under the
laws of the state in which he practices. See, e.g., James L. Hooper, 76
FR at 71,371-72; Sheran Arden Yeates, M.D., 71 FR 39,130, 39,131
(2006); Dominick A. Ricci, M.D., 58 FR 51,104, 51,105 (1993); Bobby
Watts, M.D., 53 FR 11,919, 11,920 (1988); Frederick Marsh Blanton, 43
FR at 27,617.
Under Ohio law, a terminal distributor of dangerous drugs ``means a
person who is engaged in the sale of dangerous drugs \3\ at retail . .
. '' and ``includes pharmacies . . . and all other persons who procure
dangerous drugs for sale or other distribution by or under the
supervision of a pharmacist . . . or any other person authorized by the
board of pharmacy.'' Ohio Rev. Code Ann. Sec. 4729.01(Q) (West 2021).
Further, Ohio law provides that, other than a licensed terminal
distributor of dangerous drugs and other inapplicable exceptions, ``no
person shall do any of the following: (a) Sell or distribute, at
retail, dangerous drugs; (b) possess for sale, at retail, dangerous
drugs; (c) possess dangerous drugs.'' Ohio Rev. Code Ann. Sec.
4729.51(E)(1) (West 2021).
---------------------------------------------------------------------------
\3\ The definition of ``dangerous drugs'' includes a drug that
``may be dispensed only upon a prescription'' under revised code
section 3719. Ohio Rev. Code. Ann. Sec. 3719.41 states that the
state board of pharmacy shall adopt rules establishing the schedules
of controlled substances ``incorporating the five schedules of
controlled substances under the federal drug abuse control laws.''
---------------------------------------------------------------------------
Here, the undisputed evidence in the record is that Registrant
surrendered its license as a terminal distributor of dangerous drugs in
Ohio. As already discussed, a terminal distributor of dangerous drugs
must be licensed to be authorized to possess or distribute controlled
substances in Ohio. Thus, because Registrant permanently and
voluntarily surrendered its Ohio state pharmacy license and, therefore,
is not authorized to dispense controlled substances in Ohio, Registrant
is not eligible to maintain a DEA registration. Accordingly, I will
order that Registrant's DEA registration be revoked.
[[Page 35338]]
Order
Pursuant to 28 CFR 0.100(b) and the authority vested in me by 21
U.S.C. 824(a), I hereby revoke DEA Certificate of Registration No.
FS7068249 issued to Spring Valley Family Pharmacy. Further, pursuant to
28 CFR 0.100(b) and the authority vested in me by 21 U.S.C. 823(f), I
hereby deny any pending application of Spring Valley Family Pharmacy to
renew or modify this registration, as well as any other pending
application of Spring Valley Family Pharmacy for additional
registration in Ohio. This Order is effective August 2, 2021.
D. Christopher Evans,
Acting Administrator.
[FR Doc. 2021-14165 Filed 7-1-21; 8:45 am]
BILLING CODE 4410-09-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on July 2, 2021.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.